Benjamin Looker Esperion Therapeutics, Inc. (ESPR) insider trading activity

Benjamin Looker is General Counsel of Esperion Therapeutics, Inc.. Currently has a direct ownership of 393,670 shares of ESPR, which is worth approximately $1.07 Million. The most recent transaction as insider was on Sep 17, 2025, when has been sold 6,267 shares (Common Stock) at a price of $2.8 per share, resulting in proceeds of $17,547. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 394K

1.89% 3M change

114.34% 12M change

Total Value Held $1.07 Million

Benjamin Looker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 17 2025	SELL Open market or private sale	$17,547 $2.8 p/Share	6,267 Reduced 1.57%	393,670 Common Stock
Jul 17 2025	SELL Open market or private sale	$1,473 $1.13 p/Share	1,304 Reduced 0.32%	399,937 Common Stock
Jun 17 2025	SELL Open market or private sale	$7,385 $1.15 p/Share	6,422 Reduced 1.58%	401,241 Common Stock
Mar 14 2025	BUY Grant, award, or other acquisition	-	224,000 Added 35.46%	407,663 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	100,000 Added 35.25%	183,663 Common Stock
Apr 19 2023	SELL Open market or private sale	$1,638 $1.27 p/Share	1,290 Reduced 1.52%	83,663 Common Stock
Mar 14 2023	BUY Grant, award, or other acquisition	-	20,500 Added 19.44%	84,953 Common Stock
Jan 18 2023	SELL Open market or private sale	$44,429 $7.0 p/Share	6,347 Reduced 8.96%	64,453 Common Stock
Jan 27 2022	BUY Grant, award, or other acquisition	-	70,800 Added 50.0%	70,800 Common Stock

Benjamin Looker

General Counsel

Ann Arbor, MI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Value

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Esperion Therapeutics, Inc.

Track Activities on ESPR

Account